Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s OCI Director Is Leaving For Private Practice

Jan 05 2017

• By Brenda Sandburg

FDA entrance sign 2016

Related Content

FDA’s New Criminal Investigations Chief Wants Global Reach

Mar 30 2015

FDA's Beleaguered Criminal Investigations Unit Now Facing Congressional Scrutiny

Sep 22 2016

Additional Topics

United States Regulation FDA Manufacturing BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window